Pfizer to pay €343m in drug case

Pfizer has agreed to plead guilty and pay €343m in fines to settle charges that Warner-Lambert, the company it acquired four years ago, flouted the law by promoting non-approved uses for one of its drugs.

The settlement with the world’s largest pharmaceutical company includes a €21.8m payment for whistleblower David Franklin, who first reported the marketing abuses to authorities.